Actinium Pharmaceuticals, Inc. (ATNM)

ASE – Real Time Price. Currency in USD

1.30

-0.04 (-2.99%)

At close: May 12, 2026, 4:00 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

90K

81K

930K

Cost of goods sold

-821K

-811K

-790K

-699K

Gross Profit

-731K

-811K

-709K

231K

Operating expenses (excl. COGS)

-36M

-41M

-51M

-34M

Operating Income

-36M

-42M

-52M

-34M

Non-operating income, total

Pretax income

-34M

-38M

-49M

-33M

Equity in earnings

Taxes

Non-controlling/minority interest

After tax other income/expense

Net income before discontinued operations

-34M

-38M

-49M

-33M

Actinium Pharmaceuticals, Inc. (ATNM)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Actinium Pharmaceuticals, Inc. (ATNM)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Actinium Pharmaceuticals, Inc. (ATNM)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Actinium Pharmaceuticals, Inc. (ATNM)

Income Statement (Annual)

Income Statement (Annual)